Clicky

ALVOTECH S.A.S(Z45) News

Z45 price today by TradingView
Date Title
Jan 27 Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Jan 26 Alvotech's (NASDAQ:ALVO) largest shareholders are private equity firms with 34% ownership, private companies own 31%